go to contents

HeartBeat.bio AG

Back to list

Facts

Founded
2021
Staff
3
Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health

Profile

HeartBeat.bio is an early-stage drug discovery company focused on the development of a high-throughput fully human 3D screening platform for heart diseases. The technology has the potential to radically change the current cardiovascular drug discovery paradigm, leading to higher success rates in clinical trials, reduced cost and time for compound development. HeartBeat.bio’s business strategy is to leverage its screening technology into multiple R

R&D:Our core technology is based on the world-wide first self-organizing cardiac organoids (Cardioids) which resemble the human physiology of a heart chamber in a way that allows for the cost-efficient and large scale in-vitro analysis of crucial clinical parameters associated with cardiac diseases and cardiotoxicity. We will initially focus our R

Similar companies in RDM biotech/pharma

Borealis Agrolinz Melamine GmbH

Organization type
RDM biotech/pharma
Region
Upper Austria
Focus
industrial processing
Details

BIT BIO Discovery GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health
Details

Accanis Biotech F

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Recardio GmbH

Organization type
RDM biotech/pharma
Region
Carinthia
Focus
human health
Details

Contact

Dr.-Bohr-Gasse 7
1030 Wien
Vienna

Contact: Michael Krebs (CEO)
Email: office@heartbeat.bio
Website